This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Postal Realty Trust (PSTL) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Postal Realty Trust (PSTL) delivered FFO and revenue surprises of +10.00% and +3.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Applied Digital's Q4 Earnings & Revenues Meet Estimates, Stock Up
by Zacks Equity Research
APLD's fiscal Q4 revenues rose 41%, and major CoreWeave contracts helped drive a sharp pre-market stock rally.
NETSTREIT (NTST) Q2 FFO and Revenues Surpass Estimates
by Zacks Equity Research
NETSTREIT (NTST) delivered FFO and revenue surprises of +3.13% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
American Healthcare REIT (AHR) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Has American Healthcare REIT, Inc. (AHR) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how American Healthcare REIT (AHR) and Apollo Commerical Finance (ARI) have performed compared to their sector so far this year.
New Strong Buy Stocks for June 6th
by Zacks Equity Research
CRDO, FERG, AHR, BKNIY and FER have been added to the Zacks Rank #1 (Strong Buy) List on June 6, 2025.
Implied Volatility Surging for American Healthcare Stock Options
by Zacks Equity Research
Investors need to pay close attention to AHR stock based on the movements in the options market lately.
Compared to Estimates, American Healthcare REIT (AHR) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for American Healthcare REIT (AHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Healthcare REIT (AHR) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
American Healthcare REIT (AHR) delivered FFO and revenue surprises of 2.70% and 0.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Hudson Pacific Properties (HPP) Beats Q1 FFO Estimates
by Zacks Equity Research
Hudson Pacific (HPP) delivered FFO and revenue surprises of 12.50% and 2.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Pebblebrook Hotel (PEB) Surpasses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 23.08% and 0.75%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
InvenTrust Properties Corp. (IVT) Meets Q1 FFO Estimates
by Zacks Equity Research
InvenTrust Properties (IVT) delivered FFO and revenue surprises of 0% and 1.40%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
American Healthcare REIT (AHR) Matches Q4 FFO Estimates
by Zacks Equity Research
American Healthcare REIT (AHR) delivered FFO and revenue surprises of 0% and 9.17%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Chatham Lodging (CLDT) Q4 FFO and Revenues Top Estimates
by Zacks Equity Research
Chatham Lodging (CLDT) delivered FFO and revenue surprises of 11.11% and 0.69%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Easterly Government Properties (DEA) Q4 FFO and Revenues Lag Estimates
by Zacks Equity Research
Easterly Government Properties (DEA) delivered FFO and revenue surprises of -3.33% and 4.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for American Healthcare (AHR) Stock Options
by Zacks Equity Research
Investors need to pay close attention to American Healthcare (AHR) stock based on the movements in the options market lately.
2 Healthcare REIT Stocks to Buy Before Moving Into 2025
by Rohit Vasant Fatarpekar
Healthcare REIT stocks are expected to benefit from an aging population, rising healthcare expenditure and technological advancements as they head into 2025.
Zacks Industry Outlook Highlights Welltower, American Healthcare REIT and Highwoods Properties
by Zacks Equity Research
Welltower, American Healthcare REIT and Highwoods Properties have been highlighted in this Industry Outlook article.
What Makes American Healthcare REIT (AHR) a New Strong Buy Stock
by Zacks Equity Research
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Equity REIT Stocks to Bet on Amid Healthy Industry Fundamentals
by Moumita C. Chattopadhyay
The Zacks REIT and Equity Trust - Other industry players such as WELL, AHR and HIW are likely to benefit from healthy fundamentals and improving demand.
Best Momentum Stocks to Buy for December 3rd
by Zacks Equity Research
VIK, AHR and ONB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 3, 2024.
Are Options Traders Betting on a Big Move in American Healthcare (AHR) Stock?
by Zacks Equity Research
Investors need to pay close attention to American Healthcare (AHR) stock based on the movements in the options market lately.
Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
What's in the Offing for American Healthcare This Earnings Season?
by Zacks Equity Research
While AHR's Q3 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses raise concerns.
MFA Financial Gears Up to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
MFA's third-quarter 2024 results are likely to reflect the benefits of loan demand. Declines in earnings assets are expected to have offset growth.